Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 95.79%146.54M | 77.36%440.31M | 82.26%334.4M | 64.39%207.11M | 19.02%74.85M | 5.38%248.26M | 12.23%183.48M | 5.80%125.99M | 9.64%62.89M | -10.31%235.58M |
| Operating revenue | 95.79%146.54M | 77.36%440.31M | 82.26%334.4M | 64.39%207.11M | 19.02%74.85M | 5.38%248.26M | 12.23%183.48M | 5.80%125.99M | 9.64%62.89M | -10.31%235.58M |
| Total operating cost | 76.78%123.59M | 53.32%373.42M | 51.79%273.44M | 43.68%171.22M | 24.04%69.91M | 9.96%243.56M | 12.68%180.15M | 6.12%119.17M | 2.51%56.36M | 9.91%221.5M |
| Operating cost | 85.56%83.57M | 73.77%257.53M | 81.74%196.77M | 64.77%121.87M | 16.89%45.04M | 2.64%148.2M | 10.21%108.27M | 3.05%73.96M | 13.52%38.53M | 0.65%144.4M |
| Operating tax surcharges | 59.64%628.57K | 35.92%2.31M | 37.89%1.79M | 12.74%1.02M | -1.46%393.74K | 52.86%1.7M | 73.63%1.3M | 54.99%905.94K | 47.21%399.56K | -45.06%1.11M |
| Operating expense | 64.58%16.77M | 34.00%48.66M | 20.69%32.51M | 22.33%20.91M | 38.65%10.19M | 43.18%36.32M | 54.82%26.94M | 68.68%17.09M | 57.18%7.35M | 38.47%25.36M |
| Administration expense | 45.00%8.52M | 11.85%29.55M | 0.72%20.16M | 2.12%13.3M | 0.15%5.88M | -10.22%26.42M | -15.08%20.02M | -16.87%13.02M | -38.80%5.87M | 86.29%29.43M |
| Financial expense | 17.35%-4.33M | -43.94%-19.76M | -56.40%-14.99M | -34.22%-10.39M | -26.75%-5.24M | -62.15%-13.73M | -493.96%-9.58M | -1,295.25%-7.74M | -1,307.25%-4.13M | -1,837.36%-8.47M |
| -Interest expense (Financial expense) | 209.54%413.83K | 28.63%958.24K | 2.65%571.72K | -9.63%329.53K | -28.99%133.69K | -70.09%744.93K | -74.46%556.93K | -75.55%364.64K | -72.36%188.29K | 689.82%2.49M |
| -Interest Income (Financial expense) | 11.42%-4.76M | -43.35%-20.79M | -52.22%-15.58M | -32.27%-10.71M | -24.18%-5.37M | -31.81%-14.5M | -169.17%-10.23M | -869.87%-8.1M | -1,116.65%-4.33M | -1,436.74%-11M |
| Research and development | 34.99%18.42M | 23.48%55.12M | 12.02%37.2M | 11.80%24.52M | 63.52%13.65M | 50.49%44.64M | 54.26%33.21M | 62.51%21.93M | 35.42%8.35M | 32.69%29.66M |
| Credit Impairment Loss | -139.47%-1.21M | -7,544.30%-4.1M | -746.30%-5.6M | -735.84%-3.7M | 58.92%-504.18K | 98.41%-53.69K | 49.11%-661.33K | 70.53%-443.09K | -747.55%-1.23M | -304.93%-3.38M |
| Asset Impairment Loss | -1,141.06%-1.1M | 52.32%-9.84M | 19.26%-6.02M | 41.77%-3.01M | 109.13%105.21K | -97.07%-20.63M | 2.12%-7.45M | -31.97%-5.17M | 50.98%-1.15M | -86.05%-10.47M |
| Other net revenue | ||||||||||
| Fair value change income | ---- | ---- | ---- | ---- | ---- | ---- | --624.66K | ---- | ---- | ---- |
| Invest income | ---- | -85.41%1.84M | -84.11%1.64M | -79.23%1.61M | -79.52%798.9K | 230.11%12.63M | 255.08%10.3M | --7.74M | --3.9M | 752.45%3.82M |
| Asset deal income | --68.14K | ---- | ---- | ---- | ---- | 99.65%-3.29K | -102.24%-3.29K | -102.24%-3.29K | -102.63%-3.29K | -616.89%-926.59K |
| Other revenue | -35.45%2.11M | -30.77%11.13M | -2.34%8.07M | 4.10%6.18M | 78.56%3.26M | 70.18%16.07M | 36.35%8.27M | 28.80%5.94M | 41.47%1.83M | -52.46%9.44M |
| Operating profit | 165.41%22.82M | 418.42%65.92M | 309.78%59.06M | 148.45%36.96M | -12.88%8.6M | 1.12%12.72M | 277.93%14.41M | 142.97%14.88M | 662.63%9.87M | -83.31%12.58M |
| Add:Non operating Income | 194.97%21.83K | -83.90%110.8K | -87.26%95K | -91.15%51.3K | -78.30%7.4K | -70.16%688.12K | -54.06%745.71K | -64.15%579.47K | -97.87%34.1K | -45.92%2.31M |
| Less:Non operating expense | 575.95%27.15K | -86.36%21.24K | -80.02%17.08K | 30.55%11.37K | --4.02K | 281.78%155.73K | 642.56%85.49K | 1,742,336.00%8.71K | ---- | -86.62%40.79K |
| Total profit | 165.25%22.82M | 398.26%66.01M | 292.35%59.14M | 139.53%37M | -13.14%8.6M | -10.73%13.25M | 177.83%15.07M | 99.61%15.45M | 242.19%9.9M | -81.29%14.84M |
| Less:Income tax cost | -1,704.32%-388.33K | 182.47%2.04M | 374.54%2.59M | 340.43%962.63K | -102.93%-21.52K | -171.83%-2.48M | 36.10%-941.95K | -50.87%-400.38K | 2,937.05%735.79K | -110.33%-910.59K |
| Net profit | 169.09%23.2M | 306.84%63.97M | 253.13%56.56M | 127.40%36.04M | -5.94%8.62M | -0.18%15.72M | 132.12%16.02M | 97.99%15.85M | 213.95%9.17M | -77.65%15.75M |
| Net profit from continuing operation | 169.09%23.2M | 306.84%63.97M | 253.13%56.56M | 127.40%36.04M | -5.94%8.62M | -0.18%15.72M | 132.12%16.02M | 97.99%15.85M | 213.95%9.17M | -77.65%15.75M |
| Net profit of parent company owners | 169.09%23.2M | 306.84%63.97M | 253.13%56.56M | 127.40%36.04M | -5.94%8.62M | -0.18%15.72M | 132.12%16.02M | 97.99%15.85M | 213.95%9.17M | -77.65%15.75M |
| Earning per share | ||||||||||
| Basic earning per share | 161.54%0.34 | 317.39%0.96 | 254.17%0.85 | 125.00%0.54 | 0.00%0.13 | -14.81%0.23 | 84.62%0.24 | 50.00%0.24 | 116.67%0.13 | -80.43%0.27 |
| Diluted earning per share | 161.54%0.34 | 317.39%0.96 | 254.17%0.85 | 125.00%0.54 | 0.00%0.13 | -14.81%0.23 | 84.62%0.24 | 50.00%0.24 | 116.67%0.13 | -80.43%0.27 |
| Other composite income | ||||||||||
| Total composite income | 169.09%23.2M | 306.84%63.97M | 253.13%56.56M | 127.40%36.04M | -5.94%8.62M | -0.18%15.72M | 132.12%16.02M | 97.99%15.85M | 213.95%9.17M | -77.65%15.75M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | -- | -- | Rongcheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.